Able Labs Recall of All Marketed Products Boosts 2005 Recall Total
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug recall totals for 2005 show the impact of FDA findings of serious GMP and data integrity problems at Able Labs, which resulted in the recall of all of the firm's marketed products and the closing of its operations.